Related by context. All words. (Click for frequent words.) 61 myopathy rhabdomyolysis 61 certolizumab 61 relapsed MM 60 RAPTIVA 60 C. diff infections 60 rituximab Rituxan 59 alemtuzumab treated 59 malignant neoplasm 59 chronic HBV 59 FluCAM arm 59 poor metabolizers 59 BARACLUDE ® 59 vaccinees 59 chronic hepatitis cirrhosis 59 achieved ACR# 59 latent celiac disease 59 concomitant antibiotics 58 TEAEs 58 severe exacerbations 58 intravenous bisphosphonates 58 adalimumab Humira 58 generalized edema 58 mitoxantrone plus 58 EXJADE 58 acromegalic patients 58 sargramostim 58 K ras mutations 58 efalizumab 58 HBeAg negative 58 ertapenem 58 tipranavir r 58 MAGE A3 ASCI 58 RSV hospitalizations 58 gemifloxacin 57 Infusion Reactions Severe 57 receiving highly emetogenic 57 Velcade bortezomib 57 elevated triglyceride levels 57 nonmelanoma skin cancers 57 prednisone prednisolone 57 induce remission 57 Chronic myeloid leukemia 57 pegIFN 57 APTIVUS r 57 genotypic resistance 57 bezafibrate 57 CIN3 57 Riluzole 57 TMP SMX 57 intracranial hemorrhage ICH 57 palivizumab 57 CIMZIA ™ 57 Natalizumab 57 Vidaza azacitidine 57 reduce serum phosphate 57 Myelosuppression 56 incidence ≥ 56 Kinoid 56 experienced virologic failure 56 hepatic enzymes 56 HCV infections 56 Viread Emtriva 56 chronic idiopathic thrombocytopenic purpura 56 ribavirin therapy 56 cefepime 56 Platinol ® cisplatin 56 heterozygous FH 56 cisplatin chemotherapy 56 placebo dexamethasone 56 nonvertebral fracture 56 biologic DMARD 56 corticosteroid dose 56 hepatitis B immunoglobulin 56 myocardial infarctions MIs 56 Arranon 56 gastrointestinal perforation 56 UCB Cimzia 56 octreotide LAR 56 serum aminotransferase levels 56 HBeAg + 56 varicella infection 56 PROCRIT ® 56 asymptomatic carriers 56 CMV infection 56 TNF antagonist 56 elevated ALT 56 baseline LDH 56 metastatic carcinoid tumors 56 Clinically significant 56 opportunistic viral infection 56 KRAS mutant tumors 56 serum sodium levels 56 moderately emetogenic 56 elevated LDH 56 ARCOXIA 56 Clostridium difficile infections 56 virologically 56 dose Iluvien 56 nonvertebral fractures 56 Hypotension 56 colorectal adenoma 56 PegIntron 56 vincristine doxorubicin 56 HBeAg positive patients 56 Peginterferon alfa 2b 56 AstraZeneca Iressa 56 neuroendocrine cancers 56 leukoencephalopathy 56 antidiabetic medication 56 acute respiratory tract infections 56 untreated celiac disease 56 oral FTY# 56 mcg kg REBETOL 55 SGPT 55 alpha interferons 55 rheumatoid arthritis psoriatic arthritis 55 transaminase levels 55 thromboembolic complications 55 TPV r 55 genital herpes infections 55 Arcalyst 55 containing abacavir 55 rufinamide 55 REMINYL ® 55 tacrolimus ointment 55 intensive statin therapy 55 torsade de pointes 55 tipranavir ritonavir 55 achieved sustained virological 55 Folate deficiency 55 severe hypersensitivity reactions 55 Eltrombopag 55 Gralise 55 neutropenia dehydration dyspnea 55 Enbrel Humira 55 peginterferon alfa 55 venlafaxine Effexor 55 CCyR 55 achieved CCyR 55 shingles herpes zoster 55 deep venous thromboses 55 candidemia 55 KRAS mutations occur 55 8mg/kg 55 seropositivity 55 SJIA 55 de aths 55 ibandronate 55 dopaminergic therapy 55 clodronate 55 arterial thromboembolic events 55 shingles vaccine Zostavax 55 receiving XGEVA 55 pneumococcal infection 55 genital ulcers 55 leucopenia 55 alefacept 55 Hepatotoxicity 55 efavirenz Sustiva 55 bacterium Neisseria meningitidis 55 aseptic meningitis 55 paliperidone ER 55 MRSA bloodstream infection 55 neutrophil counts 55 pulmonary exacerbations 55 WNV encephalitis 55 Tysabri monotherapy 55 motesanib 55 Noxafil 55 mcg doses 55 Myfortic 55 clobazam 55 CsA 55 prolonged QT interval 55 Removab 55 severe neutropenia 55 golimumab CNTO 55 Campylobacter infections 55 imipenem 55 NNRTI resistance 55 mycophenolate mofetil 55 Cimzia TM 55 Amgen Neulasta ® 55 beta interferons 55 HIV HCV coinfected 55 enoxaparin Lovenox 55 seroconverted 55 cidofovir 55 Lantus insulin 55 viral titers 55 vismodegib 55 ALT elevations 54 protease inhibitor PI 54 C. difficile colitis 54 transaminase elevations 54 Chronic lymphocytic leukemia 54 Listeria infections 54 acid suppressive medications 54 R abatacept 54 Dacogen decitabine 54 neuropsychiatric symptoms 54 lichen planus 54 XEPLION R 54 transplanted livers 54 EDARBI 54 anagrelide 54 fluoroquinolone resistance 54 Pemetrexed 54 liver transaminases 54 fosamprenavir 54 hepatitis C genotype 54 STELARA ™ 54 definite stent thrombosis 54 biochemical relapse 54 hypereosinophilic syndrome 54 methylmalonic acid 54 HBeAg positive 54 alanine aminotransferase ALT 54 recurrent genital herpes 54 serum urate levels 54 Decitabine 54 GRALISE 54 EGFRIs 54 dalteparin 54 PASI scores 54 Erythropoietic therapies may 54 ritonavir boosted 54 anticoagulant warfarin 54 IXEMPRA 54 myelodysplastic myeloproliferative diseases 54 Postmenopausal hormone therapy 54 Prostatitis 54 adverse cytogenetics 54 hypophosphatemia 54 medulloblastoma tumors 54 inflammatory biomarkers 54 ORENCIA ® 54 dermatologic reactions 54 thrombocytopenic 54 immune reconstitution syndrome 54 MS relapses 54 G#DT 54 dengue hemorrhagic fever DHF 54 mg dosed twice 54 chlamydial infections 54 antiepileptic medications 54 hepatorenal syndrome 54 interstitial pneumonia 54 rebleeding 54 immune thrombocytopenic purpura ITP 54 C difficile infection 54 ULORIC 54 HIV coinfected 54 campylobacter infections 54 FOLFIRI alone 54 MGUS 54 thalidomide Thalomid 54 autoantibody positive 54 EBV infection 54 severe asthma exacerbations 54 neurologic complications 54 recurrent UTI 54 Enbrel rheumatoid arthritis 54 GBA mutations 54 ZOLINZA 54 Fanconi syndrome 54 romiplostim 54 digoxin toxicity 54 HIB vaccine 54 Anaplasmosis 54 squamous cell lung cancer 54 neuropsychiatric adverse 54 Gleevec imatinib mesylate 54 emtricitabine tenofovir 54 hemorrhagic cystitis 54 CLL SLL 54 T2DM 54 interferon alfa 2a 54 renal toxicity 54 corticosteroid dexamethasone 54 tamoxifen Nolvadex ® 54 Angioedema 54 ZACTIMA 54 Sutent sunitinib 54 hypersensitivity allergic reactions 54 haematological toxicity 54 RMSF 54 thyrotropin levels 54 Fingolimod 54 mg ustekinumab 54 receiving immunosuppressive therapy 54 aminotransferases 54 aspirin clopidogrel 54 complete cytogenetic response 54 atazanavir ritonavir 54 #OHD levels 54 leukemia AML 54 Hazard Ratio 54 NMDA receptor antagonists 54 chronic urticaria 54 benazepril 54 hepatitis B infection 54 idiopathic PAH 54 lymphomas leukemias 54 squamous histology 54 anemia hemoglobin 54 divalproex sodium 54 abnormal Pap smear 54 P. falciparum malaria 54 lumiracoxib 54 HBeAg negative patients 54 Sensipar 54 ano genital warts 54 genital ulcer disease 54 serum calcium levels 54 ALT flares 54 PSA nadir 54 hematopoietic cancers 54 Chlamydia trachomatis infection 53 Viral load 53 Parnate 53 C. difficile infections 53 RBC transfusions 53 transaminases 53 Sebivo 53 acute gout flares 53 mycophenolate 53 allogeneic HSCT 53 coinfection 53 endometrial hyperplasia 53 MCyR 53 dexrazoxane 53 Pegasys plus Copegus 53 ASCUS 53 basal cell nevus syndrome 53 receiving VICTRELIS 53 LEXIVA 53 HeFH 53 Ischemic strokes 53 EDSS scores 53 Pancreatic neuroendocrine tumors 53 acarbose 53 recurrent myocardial infarction 53 oral ribavirin 53 undetectable viral 53 atorvastatin #mg 53 EGFR mutation positive 53 thiopurine 53 timepoints 53 anemia neutropenia 53 BMPR2 53 invasive ductal breast cancer 53 mepolizumab 53 cGy 53 BRCA1 mutation carriers 53 liver transplant recipients 53 Opportunistic infections 53 concomitant medications 53 cholinesterase inhibitor 53 hypocalcaemia 53 dose cohort 53 PSMA ADC 53 neuropsychiatric events 53 LV dysfunction 53 bacteriuria 53 mesalamine granules 53 decompensated liver disease 53 oesophageal adenocarcinoma 53 natalizumab 53 pamidronate 53 BEXXAR Therapeutic Regimen 53 nevirapine Viramune 53 QTcF 53 pediatric acute lymphoblastic 53 mmHg diastolic 53 Kepivance 53 nonmelanoma 53 oral prednisolone 53 osteosarcomas 53 dosing intervals 53 serum creatinine levels 53 upper gastrointestinal bleeding 53 campylobacteriosis 53 gadobutrol 53 daily subcutaneous injections 53 rhinoconjunctivitis 53 Aptivus ® 53 mCRC patients 53 clot busting therapy 53 C1 INH deficiency 53 gemcitabine Gemzar 53 serious pneumococcal infections 53 interferon alfa 2b 53 serum homocysteine 53 herpes zoster 53 M. catarrhalis 53 albumin excretion rate 53 macrolide antibiotic 53 low dose Iluvien 53 underactive thyroids 53 Gleevec resistant 53 CLINICAL STUDIES 53 Laquinimod 53 VaD 53 FOLFOX4 alone 53 canakinumab 53 somatostatin analogs 53 colorectal cancer incidence 53 Mylotarg 53 atrophic gastritis 53 RLAI 53 Gattex 53 lymphocyte count 53 Genetic mutation 53 achieved sustained virologic 53 antiretroviral naïve 53 herpes zoster shingles 53 Cognitive impairment 53 idiopathic thrombocytopenic purpura ITP 53 familial ALS 53 Targretin capsules 53 Avandia Actos 53 Renal impairment 53 advanced adenoma 53 serum phosphate 53 cranial irradiation 53 oxypurinol 53 immunosuppression therapy 53 metastatic malignant 53 weekly subcutaneous injections 53 invasive Hib 53 Retreatment 53 ESBL producing E. coli 53 diabetic kidney 53 viraemia 53 heavily pretreated 53 Liver cirrhosis 53 elevated bilirubin 53 methotrexate monotherapy 53 renal cell carcinomas 53 HbF 53 trastuzumab Herceptin ® 53 Staphylococcus aureus infections 53 maintaining Hb 53 briakinumab 53 recurrent glioblastoma multiforme 53 cells μL 53 immunosuppressive therapies 53 VZV 53 Intravenous immunoglobulin 53 adjuvant cisplatin 53 splenectomized patients 53 rizatriptan 53 Febrile neutropenia 53 HERCEPTIN 53 potentially hepatotoxic 53 chlorambucil 53 paricalcitol 53 advanced hepatocellular carcinoma 52 .5 milligrams 52 Vandetanib 52 pemetrexed Alimta 52 SIMPONI ® 52 de ath 52 BRAF V# mutation 52 suppressive therapy 52 gastrointestinal toxicity 52 receiving prophylactic anticoagulation 52 precancerous cervical 52 interferon ribavirin 52 moderate renal impairment 52 infectious syphilis 52 fetal malformations 52 anticonvulsant medications 52 Vibrio infections 52 peginterferon alpha 2a 52 Pegylated Interferon 52 gefitinib Iressa 52 recurrent ischemia 52 acute rheumatic fever 52 prednisone prednisolone plus 52 monoinfected patients 52 CMV disease 52 hepatocellular carcinomas 52 probiotic supplementation 52 sustained virological response 52 antibody titer 52 receiving INTRON 52 PRADAXA #mg 52 equine WNV 52 valacyclovir 52 paliperidone palmitate 52 hematologic abnormalities 52 HbA1C levels 52 pegylated liposomal doxorubicin 52 haemorrhagic stroke 52 conventional antipsychotics 52 Skin rashes 52 foodborne infections 52 nephrotoxicity 52 clomipramine 52 levodopa therapy 52 Vitamin B# deficiency 52 plus methotrexate 52 erlotinib Tarceva 52 INVEGA ® 52 TNF blocker therapy 52 MIRCERA 52 nilotinib 52 cabazitaxel 52 urine albumin 52 TT genotype 52 AUC0 #hr 52 Chronic Myelogenous Leukemia CML 52 Heavy menstrual bleeding 52 symptomatic paroxysmal AF 52 PASI score 52 Lamictal XR 52 Guillain Barré 52 Cancidas 52 differentiated thyroid 52 COMBIVIR 52 #.#mg dose 52 corticosteroid therapy 52 oral hypoglycemic 52 postoperative mortality 52 MMRV 52 multivariable adjusted 52 gastrointestinal reflux 52 nonnucleoside reverse transcriptase inhibitors 52 LHRH agonists 52 chronic lymphoid leukemia 52 Adjuvant chemotherapy 52 recurrent VTE 52 Potiga 52 Menopausal hormone therapy 52 milliliters mL 52 prior chemotherapy regimens 52 Adverse effects 52 non valvular atrial 52 neutropenic patients 52 hypomagnesemia 52 ceftriaxone 52 pancytopenia 52 nonmelanoma skin cancer 52 RAS blockers 52 basal cell carcinomas 52 antidiabetic drug 52 induce orthostatic hypotension 52 NOMID 52 atazanavir 52 abacavir lamivudine 52 mg eq 52 bendamustine 52 progressive multifocal PML 52 alfa 2a 52 chlamydial infection 52 COPD exacerbations 52 AZT zidovudine Retrovir 52 detemir 52 liver enzymes ALT 52 lopinavir ritonavir Kaletra 52 Telintra 52 μg doses 52 thrombocytopenic patients 52 Zavesca R 52 polytherapy 52 seropositive patients 52 NQO1 52 apneic episodes 52 Chemotherapy induced 52 bovine thrombin 52 TroVax ® 52 pCR 52 Kaplan Meier estimates 52 Pazopanib 52 piperacillin tazobactam 52 Kaletra lopinavir ritonavir 52 nonsevere 52 syncope fainting 52 serum ALT 52 chronic granulomatous disease 52 antiangiogenic drugs 52 liver metastasis 52 lymphocytosis 52 invasive ductal 52 basal cell carcinoma BCC 52 Primary IGFD 52 severe periodontitis 52 Mg Uk 52 dyskeratosis congenita 52 MMRV vaccine 52 thrombotic events 52 bardoxolone methyl 52 buprenorphine implants 52 autologous transplants 52 doxorubicin docetaxel 52 histologic subtype 52 morphometric vertebral fractures 52 HBeAg seroconversion 52 PEG INTRON 52 symptomatic intracranial hemorrhage 52 azathioprine 52 Kivexa 52 #mg #mg #mg [003] 52 paralytic polio 52 arterial thromboembolism 52 Egrifta 52 glycated hemoglobin levels 52 VELCADE melphalan 52 Twinrix 52 cytotoxic therapies 52 Acute myeloid leukemia 52 cytopenia 52 plasminogen activators 52 annualized relapse 52 calcineurin inhibitor 52 TDF FTC 52 CIMZIA TM certolizumab pegol 52 antibody titers 52 nadroparin 52 Hemolytic uremic syndrome 52 dexamethasone Decadron 52 iniparib BSI 52 systemic corticosteroid 52 Replikin Count 52 cART 52 lenalidomide dexamethasone 52 aspartate aminotransferase AST 52 Irinotecan Hydrochloride Injection 52 elevated transaminases 52 cerebrovascular events 52 beta carotene supplementation 52 hormone receptor negative 52 postoperative delirium 52 herpes zoster vaccine 52 inhospital 52 SSRI prescriptions 52 anastrazole 52 plasma folate 52 nonhereditary 52 GSTM1 52 metastatic malignant melanoma 52 posaconazole 52 adalimumab etanercept 52 FASLODEX 52 quetiapine Seroquel 51 deletion 5q 51 circulating EPCs 51 Valcyte 51 thromboembolic disease 51 glulisine 51 homocysteine concentrations 51 blood thinner Warfarin 51 bioavailable testosterone 51 coinfected 51 Firazyr 51 evaluable subjects 51 post herpetic neuralgia PHN 51 oxycodone CR 51 medullary thyroid cancer 51 Skin sterol 51 AGGRASTAT ® tirofiban hydrochloride 51 severe renal impairment 51 gemcitabine carboplatin 51 Thal Dex 51 AGILECT R 51 AGILECT ® 51 Tardive dyskinesia 51 FIRMAGON 51 Cladribine tablets 51 NATRECOR R 51 cotrimoxazole 51 del 5q MDS 51 hormone deprivation 51 chlamydia infections 51 hematologic toxicity 51 IFN alfa 51 cystic fibrosis chronic pancreatitis 51 Plaquenil 51 TMC# r 51 initiating HAART 51 undetectable viral loads 51 inhaled iloprost 51 Ellence 51 DETROL LA 51 alteplase 51 Pfizer Aricept 51 Pneumococcal pneumonia 51 Gemzar gemcitabine 51 receiving APTIVUS r 51 fluconazole resistant 51 FOLFIRINOX 51 WNV infections 51 #mg/m# [001] 51 dengue haemorrhagic fever DHF 51 anakinra 51 relapsed CLL 51 thrombocytosis 51 pH#N# 51 maximal doses 51 thromboembolic events 51 Relapsing remitting MS 51 epirubicin 51 PegIFN RBV 51 pyrazinamide 51 mitoxantrone chemotherapy 51 cerebral vasospasm 51 epoetin 51 pravastatin Pravachol 51 Zometa zoledronic acid 51 Doxil ® 51 Zemplar Capsules 51 herpes zoster infection 51 atherothrombotic events 51 pyridostigmine 51 HIV seroprevalence 51 exenatide Byetta 51 thiazides 51 URTI 51 alanine aminotransferase 51 trivalent inactivated influenza 51 abiraterone acetate 51 indinavir 51 myeloproliferative neoplasms 51 viremic 51 vaccine serotypes 51 sulfasalazine 51 haematologic 51 insomnia sufferers 51 Waldenstrom macroglobulinemia 51 zidovudine lamivudine 51 Crohn Disease Activity 51 nucleoside analogs 51 Cinquil 51 selegiline 51 metastatic GIST 51 Forodesine HCl 51 low dose cytarabine 51 neurological manifestations 51 airway hyper responsiveness 51 underwent surgical resection 51 CHOP chemotherapy 51 MGd 51 genotype 1b 51 multiple sclerosis lupus 51 myocardial infarctions 51 hydroxyvitamin D levels 51 Hydroxyurea 51 standard chemotherapy regimen 51 Postherpetic neuralgia 51 sexually transmitted HPV 51 oral vancomycin 51 REYATAZ ® 51 recurrent wheezing 51 Folic acid supplements 51 Hypocalcemia 51 venous blood clots 51 hyperprolactinemia 51 pentoxifylline 51 tickborne 51 cardiovascular disease hypertension 51 basiliximab 51 spontaneous preterm delivery 51 virologic breakthrough 51 non aspirin NSAIDs 51 immunocompromised individuals 51 tumor regressions 51 ticagrelor Brilinta 51 tibolone 51 Torsades de Pointes 51 Zometa hazard 51 Neupro patch 51 SCr 51 mg simvastatin 51 PLX STROKE targeting 51 CVD mortality 51 simvastatin ezetimibe 51 neoadjuvant radiation 51 hydroxychloroquine 51 Syndrome RLS 51 venous thromboembolic disease 51 Azathioprine 51 Actelion Tracleer 51 lung cancer NSCLC 51 adjunctive ABILIFY 51 extrapyramidal symptoms 51 Toxicities 51 combination antiretroviral therapy 51 QT interval prolongation 51 RISPERDAL ® 51 CK # plasma concentrations 51 Chronic ITP 51 bacterial prostatitis 51 T2 lesion volume 51 asymptomatic bacteriuria 51 clostridium difficile infection 51 chronic HCV infection 51 nucleoside naive 51 ug dose 51 recurrent venous thromboembolism 51 INVEGA ™ 51 NovoLog ® Mix 51 severe rotavirus gastroenteritis 51 adult chronic ITP 51 K ras gene 51 docetaxel Taxotere ® 51 invasive fungal infection 51 adrenocortical cancer 51 mcg dose 51 hypercholesterolaemia 51 CR CRu 51 SUSTENNA TM 51 albumin excretion 51 MELAS 51 symptom flare ups 51 DEB# 51 cryptococcal meningitis 51 BENICAR HCT 51 RBC folate 51 angiotensin receptor blockers ARBs 51 Darapladib 51 sCJD 51 leukocyte counts 51 mucosal healing 51 pancreatic enzyme replacement 51 fibrate drugs 51 Onrigin 51 rFVIIa 51 lipid lowering medications 51 transfusion transmitted 51 Aortic stenosis 51 azilsartan medoxomil 51 antiepileptic drugs AEDs 51 acetaminophen codeine 51 abatacept 51 Wartime PTSD 51 cells/mm3 51 infliximab Remicade 51 locoregional recurrence 51 shorter telomere length 51 hyperphenylalaninemia HPA due 51 mycophenolate mofetil MMF 51 nighttime awakenings 51 Lucentis injections 51 achieve sustained virologic 51 hepatic cirrhosis 51 cytopenias 51 tenofovir emtricitabine 51 Zidovudine Tablets 51 orchitis 51 adriamycin 51 IOP lowering 51 thrombotic complications 51 ® lenalidomide 51 estramustine 51 distant metastasis 51 Uncontrolled hypertension 51 flavonoid intake 51 ARIXTRA 51 renal flares 51 erythema redness 51 parkinsonian symptoms 51 autonomic dysfunction 51 pegylated interferon alfa 51 ALT elevation 51 vibriosis 51 vasogenic edema 51 gemcitabine cisplatin 51 hemorrhagic complications 51 neutropenic 51 daunorubicin 51 undergone splenectomy 51 paclitaxel Taxol ® 51 CHD CVD 51 virologic failure 51 venous thromboembolisms 51 postoperative chemotherapy 51 virological response 51 serum urate 51 lenalidomide Revlimid R 51 Platelet counts 51 Chlamydia infection 51 abnormal Pap smears 51 platelet reactivity 51 fragility fractures 51 triglyceride concentrations 51 pegylated interferon alpha 50 Stage IIB 50 leukemia APL 50 debulking surgery 50 Danazol 50 PNH patients 50 hepatotoxicity 50 pouchitis 50 Uterine cancer 50 Pharmacokinetics PK 50 relapsing remitting 50 abnormal ejaculation 50 commonest cancers 50 hepatic fibrosis 50 severe hepatic insufficiency 50 treatment naive genotype 50 amprenavir 50 midstage clinical 50 gastrointestinal ulcers 50 ALTACE 50 chorioamnionitis 50 imatinib resistance 50 Thrombocytopenia 50 CETP gene 50 generalized tonic clonic seizures 50 serum PTH 50 TNF blocker 50 antiandrogens 50 pegylated interferon alfa 2a 50 dosage regimens 50 nortriptyline 50 acute porphyria 50 CP CPPS 50 CC genotype 50 conjugated estrogens 50 isoproterenol 50 coinfected patients 50 Advagraf 50 tumor lysis syndrome 50 mIU ml 50 Peripheral edema 50 Pandemic Influenza H#N# 50 immune modulating 50 chemo radiotherapy 50 Postoperative complications 50 sulfonylurea metformin 50 BeneFIX 50 pegfilgrastim 50 JAK2 enzyme 50 Colon polyps 50 reinfarction 50 serologic testing 50 treat NNT 50 gastroesophageal reflux GERD 50 cutaneous squamous cell carcinoma 50 primary IGFD 50 cilostazol 50 postexposure prophylaxis 50 HER2 expression 50 antiplatelet medications 50 Chlamydia infections 50 sevelamer hydrochloride 50 hepatitis C infections 50 nonfatal occupational 50 Presents Preclinical 50 nadolol 50 aprepitant 50 GH deficiency 50 hereditary predisposition 50 overt hepatic encephalopathy 50 hepatic toxicity 50 events TEAEs 50 evaluating tivozanib 50 WNV infection 50 Smallpox vaccine 50 progesterone receptor negative 50 chronic eosinophilic leukemia 50 HPV subtypes 50 Peginterferon 50 post transplant lymphoproliferative 50 samalizumab 50 Zavesca ® 50 myelogenous leukemia 50 ICD shocks 50 ACZ# 50 Multidrug resistant 50 refractory gout 50 Revlimid lenalidomide 50 antithymocyte globulin 50 adverse reactions occurring 50 atopic disorders 50 Myelodysplastic syndromes 50 liver scarring 50 interferon beta therapy 50 normal ULN 50 abnormal pap smears 50 CPAP adherence 50 hepatic encephalopathy HE 50 hepatitis C infection 50 urate lowering 50 Hematologic toxicity 50 fibrinolytic 50 LUCENTIS 50 temozolomide TMZ 50 seroprotection 50 androgen deprivation 50 intravenous immunoglobulin IVIg 50 subcutaneous dose 50 baseline HbA1c 50 sustained virologic response 50 nonmetastatic prostate cancer 50 elevated creatinine